This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bordeleau L, Berinstein NL. Molecular diagnostics in follicular non-Hodgkin’s lymphoma. Semin Oncol 2000;27(6 Suppl 12):42–52
Burmeister T, Thiel E. Molecular genetics in acute and chronic leukemias. J Cancer Res Clin Oncol 2001;127:80–90
Grimwade D, Walker H, Oliver F et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998;92:2322–33
Harrison CJ. The management of patients with leukaemia: the role of cytogenetics in this molecular era. Br J Hematol 2000;108:19–30
Huret JL, Dessen P, LeMinor S et al. The “Atlas of Genetics and Cytogenetics in Oncology and Haematology” on the internet and a review on infant leukemias. Cancer Genet Cytogenet 2000;120:155–9
Kristensen TD, Wesenberg F et al. High-resolution comparative genomic hybridisation yields a high detection rate of chromosomal aberrations in childhood acute lymphoblastic leukaemia. Eur J Haematol 2003;70:363–72
Mrozek K, Heinonen K, Bloomfield CD. Prognostic value of cytogenetic findings in adults with acute myeloid leukemia. Int J Hematol 2000;72:261–71
http://www.ncbi.nlm.nih.gov/Genbank/GenbankOverview.html NIH gene database
http://www.gdb.org/ Human Genome Database
http://atlasgeneticsoncology.org/ Atlas of Genetics and Cytogenetics
http://www.slh.wisc.edu/cytogenetics/index.php Cancer Cytogenetics
http://www.biologia.uniba.it/rmc/ Molecular Cytogenetics Resources
http://www.genenames.org/ Human Gene Nomenclature
Cassinat B, Zassadowski F, Balitrand N et al. Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT–PCR. Leukemia 2000;14:324–8
Krauter J, Pascheberg U, Heinze B et al. Detection of karyotypic aberrations in acute myeloblastic leukemia (AML): a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML. Br J Haematol 1998;103:72–8
Perez EA, Pusztai L, Van de Vijver M. Improving patient care through molecular diagnostics. Semin Oncol 2004;31(5 Suppl 10):14–20
Schoch C, Kohlmann A et al. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expressions profiles. Proc Natl Acad Sci U S A 2002;99:10008–13
Staudt LM. Molecular diagnosis of the hematologic cancers. N Engl J Med 2003;348:1777–85
Varella-Garcia M. Molecular cytogenetics in solid tumors: laboratorial tool for diagnosis, prognosis, and therapy. Oncologist 2003;8:45–58
http://jmd.amjpathol.org Journal of Molecular Diagnostics
http://www.acmg.net/ American College of Medical Genetics
http://www.abgc.net/ American Board of Genetic Counseling
http://www.eshg.org European Society of Human Genetics
http://www.eurogene.org/index.php European Genetics Foundation
http://genetics.faseb.org/genetics/acmg/stds/g.htm ACMG Standards and Guidelines
Baak JPA, Path FRC, Hermsen MAJA et al. Genomics and proteomics in cancer. Eur J Cancer 2003;39:1199–215
Bullinger L, Döhner K, Bair E et al. Use of gene expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004;350:1605–16
Ebert BL, Golub TR. Genomic approaches to hematologic malignancies. Blood 2004;104:923–32
Hubank M. Gene expression profiling and its application in studies of haematological malignancy. Br J Haematol 2004;124:577–94
Quackenbush J. Microarray analysis and tumor classification. N Engl J Med 2006; 354:2463–72
Ramaswamy S, Ross KN, Lander ES et al. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49–54
Rosenwald AR, Wright G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937–47
Van de Vijver MJ, He YD, van’t Veer LJ et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999–2009
http://dc.nci.nih.gov/dc/ NCI, Molecular Classification of Cancer
http://genome-www5.stanford.edu/ Stanford Microarray Database
http://www.ebi.ac.uk/arrayexpress/ EBI Transciptional Database
http://www.genome.ad.jp/kegg/kegg2.html KEGG, Biochemical Pathways
http://genmapp.org GenMapp, Biochemical Pathways
http://affymetrix.com Affymetrix Microarrays
Brawer MK. Prostate-specific antigen: current status. CA Cancer J Clin 1999;49:264–81
Gion M, Mione R, Barioli P et al. Dynamic use of tumor markers: rationale, clinical applications and pitfalls. Anticancer Res 1996;16:2279–84
Locker GY, Hamilton S, Harris J et al. ASCO 2006 Update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313–27
Rapkiewicz AV, Espina V, Petricoin EF et al. Biomarkers of ovarian tumours. Eur J Cancer 2004;40:2604–12
Scher HI, Eisenberger M, D’Amico AV et al. Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen. Recommendations from the PSA Working Group. J Clin Oncol 2004;22:537–56
Sölétormos G, Nielsen D, Schioler V et al. Monitoring different stages of breast cancer using tumour markers CA 15-3, CEA and TPA. Eur J Cancer 2004;40:481–6
http://www.asco.org ASCO Tumor Marker Guidelines
http://oncolink.upenn.edu/ Oncolink, Tumor Marker Fact Sheet
http://cancernet.nci.nih.org/ Tumor Marker Fact Sheets
Bene M, Castoldi G, Knapp W et al. Proposals for the immunological classification of acute leukemias. Leukemia 1995;9:1783–6
Bennett J, Catovskz D, Daniel M et al. Proposed revised criteria for the classification of acute myeloid leukemias. Ann Intern Med 1985;103:626–9
Cheson B, Cassileth P, Head D et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990;8:813–9
Gratama JW, Sutherland DR, Keeney M. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. Semin Hematol 2001;38:139–47
Harris NL, Jaffe E, Stein H et al. A Revised European-American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361–92
Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Advisory Committee meeting, Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835–49
Mason D et al (eds). Leucocyte Typing VII. Oxford University Press, 2001
Stetler-Stevenson M, Braylan RC. Flow cytometric analysis of lymphomas and lymphoproliferative disorders. Semin Hematol 2001;38:111–23
Vardiman J, Harris NL, Brunning RD; the World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292–2302
Zola H, Swart B, Nicholson I et al. CD molecules 2005: Human cell differentiation molecules. Blood 2005;106:3123–3126
http://image.bloodline.net/ Picture Atlas, Bloodline
http://www.hlda8.org HLDA Workshop
http://mpr.nci.nih.quv/prow Flow Cytometry Database
Fisch P, Moris A, Rammensee HG et al. Inhibitory MHC class I receptors on gammadelta T cells in tumour immunity and autoimmunity. Immunol Today 2000;21:187–191
Godsell DS. The molecular perspective: MHC. Oncologist 2005;10:80–1
Klein J, Sato A. The HLA System. N Engl J Med 2000;243:702–9, 782–6
Marsh SG, Bodmer JG, Albert ED et al. Nomenclature for factors of the HLA system, 2000. Tissue Antigens 2001;57:236–83
http://www.ashi-hla.org/ American Society for Histocompatibility and Immunogenetics
http://www.ihwg.org/ International Histocompatibility Working Group
http://www.worldmarrow.org WMDA, World Marrow Donor Association
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kunzmann, R. et al. (2008). Special Diagnostics. In: Berger, D., Engelhardt, M., Henß, H., Mertelsmann, R. (eds) Concise Manual of Hematology and Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-73277-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-540-73277-8_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-73276-1
Online ISBN: 978-3-540-73277-8
eBook Packages: MedicineMedicine (R0)